A Study in Healthy Volunteers to Assess the Tolerability and Blood Levels of a Single Dose of AZD7687
|ClinicalTrials.gov Identifier: NCT01046357|
Recruitment Status : Completed
First Posted : January 12, 2010
Last Update Posted : February 13, 2012
This is a Phase I, first time in human, randomised, blinded, placebo-controlled, single ascending dose study in healthy male volunteers conducted at a single centre. The effect of food on the pharmacokinetics of AZD7687 will also be studied.
The study will consist of two parts, a dose escalation part and a food interaction part. The two parts will be run in parallel. In total, 64 healthy volunteers divided in 8 different panels (8 volunteers per cohort) will be exposed to single doses during the dose escalation. Each subject will receive dose only once, except for the volunteers included in the dose steps repeated for food interaction.
|Condition or disease||Intervention/treatment||Phase|
|Healthy||Drug: AZD7687 Drug: Placebo||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||64 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)|
|Official Title:||A Randomized, Blind, Placebo-controlled, Single-centre Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of AZD7687 After Single Ascending Oral Doses|
|Study Start Date :||November 2009|
|Actual Primary Completion Date :||June 2010|
|Actual Study Completion Date :||June 2010|
AZD7687 oral suspension
Single oral dose
placebo oral suspension
Single oral dose
- Safety variables (adverse events, vital signs, physical examination, telemetry, digital electrocardiograms (dECGs), safety 12-lead paper electrocardiograms (pECG), and clinical laboratory assessments)
- Plasma concentrations of AZD7687 and plasma pharmacokinetic parameters.
- Exploratory pharmacogenetic blood sampling.
- Pharmacodynamic biomarker sampling; blood samples.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01046357
|United States, Kansas|
|Overland Park, Kansas, United States|